Enoch Kariuki Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Enoch Kariuki is Director of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 137,365 shares of ZNTL, which is worth approximately $196,431. The most recent transaction as insider was on Jun 17, 2025, when has been sold 57,603 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
72.22% 3M change
72.22% 12M change
Total Value Held $196,431

Enoch Kariuki Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2025
BUY
Grant, award, or other acquisition
-
57,603 Added 29.54%
137,365 Common Stock
Jun 21 2024
BUY
Grant, award, or other acquisition
-
41,581 Added 34.27%
79,762 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
16,364 Added 30.0%
38,181 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
21,817 Added 50.0%
21,817 Common Stock

Also insider at

IMGO
Imago BioSciences, Inc. Healthcare
Director
EK

Enoch Kariuki

Director
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL